Bimolecular fluorescence complementation
≈ 15 min read
Names in other languages
- EnglishBimolecular fluorescence complementation
- DeutschBimolekulare Fluoreszenzkomplementation
- עבריתהשלמה פלואורסצנטית ביומולקולרית
- 日本語二分子蛍光補完
- 中文双分子荧光互补
- 中文双分子荧光互补
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Bimolecular fluorescence complementation (also known as BiFC) is a technology typically used to validate protein interactions. It is based on the association of fluorescent protein fragments that are attached to components of the same macromolecular complex.
Proteins that are postulated to interact are fused to unfolded complementary fragments of a fluorescent reporter protein and expressed in live cells. Interaction of these proteins will bring the fluorescent fragments within proximity, allowing the reporter protein to reform in its native three-dimensional structure and emit its fluorescent signal.
This fluorescent signal can be detected and located within the cell using an inverted fluorescence microscope that allows imaging of fluorescence in cells. In addition, the intensity of the fluorescence emitted is proportional to the strength of the interaction, with stronger levels of fluorescence indicating close or direct interactions and lower fluorescence levels suggesting interaction within a complex.
Therefore, through the visualisation and analysis of the intensity and distribution of fluorescence in these cells, one can identify both the location and interaction partners of proteins of interest.
Bimolecular fluorescence complementation (also known as BiFC) is a technology typically used to validate protein interactions. It is based on the association of fluorescent protein fragments that are attached to components of the same macromolecular complex.
Proteins that are postulated to interact are fused to unfolded complementary fragments of a fluorescent reporter protein and expressed in live cells. Interaction of these proteins will bring the fluorescent fragments within proximity, allowing the reporter protein to reform in its native three-dimensional structure and emit its fluorescent signal.
This fluorescent signal can be detected and located within the cell using an inverted fluorescence microscope that allows imaging of fluorescence in cells. In addition, the intensity of the fluorescence emitted is proportional to the strength of the interaction, with stronger levels of fluorescence indicating close or direct interactions and lower fluorescence levels suggesting interaction within a complex.
Therefore, through the visualisation and analysis of the intensity and distribution of fluorescence in these cells, one can identify both the location and interaction partners of proteins of interest.
History
Biochemical complementation was first reported in subtilisin-cleaved bovine pancreatic ribonuclease, then expanded using β-galactosidase mutants that allowed cells to grow on lactose. Recognition of many proteins' ability to spontaneously assemble into functional complexes as well as the ability of protein fragments to assemble as a consequence of the spontaneous functional complex assembly of interaction partners to which they are fused was later reported for ubiquitin fragments in yeast protein interactions.
In 2000, Ghosh et al developed a system that allowed a green fluorescent protein (GFP) to be reassembled using an anti-parallel leucine zipper in E. coli cells. This was achieved by dissecting GFP into C- and N-terminal GFP fragments.
As the GFP fragment was attached to each leucine zipper by a linker, the heterodimerisation of the anti-parallel leucine zipper resulted in a reconstituted, or re-formed, GFP protein that could be visualised. The successful fluorescent signal indicated that the separate GFP peptide fragments were able to correctly reassemble and achieve tertiary folding.
It was, therefore, postulated that using this technique, fragmented GFP could be used to study interaction of protein–protein pairs that have their N–C termini in close proximity. After the demonstration of successful fluorescent protein fragment reconstitution in mammalian cells, Hu et al. described the use of fragmented yellow fluorescent protein (YFP) in the investigation of bZIP and Rel family transcription factor interactions.
This was the first report bZIP protein interaction regulation by regions outside of the bZIP domain, regulation of subnuclear localization of the bZIP domains Fos and Jun by their different interacting partners, and modulation of transcriptional activation of bZIP and Rel proteins through mutual interactions. In addition, this study was the first report of an in vivo technique, now known as the bimolecular fluorescence complementation (BiFC) assay, to provide insight into the structural basis of protein complex formation through detection of fluorescence caused by the assembly of fluorescent reporter protein fragments tethered to interacting proteins.
Selection of fusion protein production system
There are different production systems that can be used for the fusion protein generated. Transient gene expression is used to identify protein–protein interactions in vivo as well as in subcellular localisation of the BiFC complex. However, one must be cautious against protein over-expression, as this may skew both preferential localisation and the predominant protein complexes formed.
Instead, weak promoters, the use of low levels of plasmid DNA in the transfection, and plasmid vectors that do not replicate in mammalian cells should be used to express proteins at or near their endogenous levels to mimic the physiological cellular environment. Also, careful selection of the fluorescent protein is important, as different fluorescent proteins require different cellular environments.
For example, GFP can be used in E. coli cells, while YFP is used in mammalian cells. Stable cell lines with the expression vector integrated into its genome allows more stable gene expression in the cell population, resulting in more consistent results.
Creating proper plasmid expression vectors
When designing plasmid vectors to express the proteins of interest, the construct must be able to express proteins that are able to form fusion proteins with fluorescent protein fragments without disrupting the protein's function. In addition, the expected protein complex must be able to accept stabilisation of the fluorescent protein fragment interaction without affecting the protein complex function or the cell being studied.
Many fluorescent protein fragments that combine in several ways can be used in BiFC. Generally, YFP is recommended to serve as the reporter protein, cleaved at residue 155 (N-terminal consisting of residues 1–154 and C-terminal consisting of residues 155–238) or residue 173 in particular, as these sets of fragments are highly efficient in their complementation when fused to many interacting proteins and they produce low levels fluorescence when fused to non-interacting proteins.
It is suggested that each target protein is fused to both the N- and C-terminal fragments of the fluorescent reporter protein in turn, and that the fragments are fused at each of the N- and C-terminal ends of the target proteins. This will allow a total of eight different permutations, with interactions being tested: N-terminal fragment fused at the N-terminal protein 1 + C-terminal fragment fused at the N-terminal protein 2 N-terminal fragment fused at the N-terminal protein 1 + C-terminal fragment fused at the C-terminal protein 2 N-terminal fragment fused at the C-terminal protein 1 + C-terminal fragment fused at the N-terminal protein 2 N-terminal fragment fused at the C-terminal protein 1 + C-terminal fragment fused at the C-terminal protein 2 C-terminal fragment fused at the N-terminal protein 1 + N-terminal fragment fused at the N-terminal protein 2 C-terminal fragment fused at the N-terminal protein 1 + N-terminal fragment fused at the C-terminal protein 2 C-terminal fragment fused at the C-terminal protein 1 + N-terminal fragment fused at the N-terminal protein 2 C-terminal fragment fused at the C-terminal protein 1 + N-terminal fragment fused at the C-terminal protein 2
Direct visualization
BiFC enables direct visualisation of protein interactions in living cells with limited cell perturbation, rather than relying on secondary effects or staining by exogenous molecules that can fail to distribute evenly. This, and the ability to observe the living cells for long periods of time, is made possible by the strong intrinsic fluorescence of the reconstituted reporter protein reduces the chances of an incorrect readout associated with the protein isolation process.
Sensitivity
Unlike many in vivo protein-interaction assays, BiFC does not require protein complexes to be formed by a large proportion of the proteins or at stoichiometric proportions. Instead, BiFC can detect interactions among protein subpopulations, weak interactions, and low expression proteins due to the stable complementation of the fluorescent reporter protein.
In addition, successful fluorescent protein reconstitution has been reported for protein partners over 7 nm apart, so long as the linkers binding the fluorophore fragment to the protein of interest has the flexibility needed to associate with its corresponding fragment. Furthermore, the strength of the protein interaction can be quantitatively determined by changes in fluorescent signal strength.
Spatial resolution
BiFC allows measurement of spatial and temporal changes in protein complexes, even in response to activating and inhibiting drugs and subcellularly, providing the highest spatial resolution of in vivo protein–protein interaction assays.
No specialised equipment
BiFC does not require specialised equipment, as visualisation is possible with an inverted fluorescence microscope that can detect fluorescence in cells. In addition, analysis does not require complex data processing or correction for other sources of fluorescence.
No structural information needed
BiFC can be performed without structural information about the interaction partners, so long as the fluorescent reporter protein fragments can associate within the complex, as multiple combinations of fusion proteins can be screened. This is due to the assumption that, since the protein functions are recapitulated in the in vivo context, the complex structure will resemble that of the intact proteins seen physiologically.
Multiple applications
The BiFC technology has been refined and expanded to include the abilities to simultaneously visualise multiple protein complexes in the same cell, RNA/protein interactions, to quickly detect changes in gene transduction pathways, demonstrate hidden phenotypes of drugs, where the predicted treatment outcome (i.e. cell death, differentiation, morphological change) is not seen in vivo, study complex formation in different cellular compartments, and to map protein interaction surfaces
Altering protein structure and steric hindrance
Fluorescent fragment linkage may alter the folding or structure of the protein of interest, leading to the elimination of an interacting protein's surface binding site. In addition, the arrangement of the fluorescent fragments may prevent fluorophore reconstitution through steric hindrance, although steric hindrance can be reduced or eliminated by using a linker sequence that allows sufficient flexibility for the fluorescent fragments to associate.
Therefore, absence of fluorescence complementation may be a false negative and does not necessarily prove that the interaction in question does not occur.
Obligate anaerobes
Due to the requirement of molecular oxygen for fluorophore formation, BiFC cannot be used in obligate anaerobes, which cannot survive in the presence of oxygen. This limits the use of BiFC to aerobic organisms.
Autofluorescence
Autofluorescence is usually not a problem since the BiFC signal will be a lot higher than the background. However certain organisms, especially apicomplexa, have a higher autofluorescence that make it harder to apply BiFC in them. Certain fungi, such as Candida albicans, also have a high autofluorescent background, but BiFC can often still be performed when the proper controls and strains are used.
Exact interaction relationship unknown
Because fluorophore reconstitution can occur at a distance of 7 nm or more, fluorescence complementation may indicate either a direct or indirect (i.e. within the same complex) interaction between the fluorescent fragments' fused proteins.
Application
In addition to the validation of protein–protein interactions described above, BiFC has been expanded and adapted to other applications:
Assembly of bacterial ribosomes
The BiFC system has been applied to record ribosome biogenesis events in E.coli. The process of ribosomes assembly involves nucleation of ribosomal proteins in proper order and orientation. Perturbations in assembly can lead to structural defects in ribosomal subunits which as a result cannot join in the correct orientation to form fully functional ribosomes.
Thus, the events of subunit joining signaled by the appearance of BiFC is an easy way to monitor ribosome biogenesis in contrast to laborious polysome profiling methods.
Multicolour fluorescence
The fluorescent protein fragments used in BiFC have been expanded to include the colours blue, cyan, green, yellow, red, cherry, and Venus. This range in colours has made the development of multicolour fluorescence complementation analysis possible. This technique allows multiple protein complexes to be visualised simultaneously in the same cell.
In addition, proteins typically have a large number of alternative interaction partners. Therefore, by fusing fragments of different fluorescent proteins to candidate proteins, one can study competition between alternative interaction partners for complex formation through the complementation of different fluorescent colour fragments.
RNA-binding protein interactions
BiFC has been expanded to include the study of RNA-binding protein interactions in a method Rackham and Brown described as trimolecular fluorescence complementation (TriFC). In this method, a fragment of the Venus fluorescent protein is fused to the mRNA of interest, and the complementary Venus portion fused to the RNA-binding protein of interest.
Similar to BiFC, if the mRNA and protein interact, the Venus protein will be reconstituted and fluoresce. Also known as the RNA bridge method, as the fluorophore and other interacting proteins form a bridge between the protein and the RNA of interest, this allows a simple detection and localisation of RNA-protein interactions within a living cell and provides a simple method to detect direct or indirect RNA-protein association (i.e. within a complex) that can be verified through in vitro analysis of purified compounds or RNAi knockdown of the bridging molecule(s).
Pathway organisation and signal transduction cascades
BiFC can be used to link genes to one other and their function through measurement of interactions among the proteins that the genes encode. This application is ideal for novel genes in which little is known about their up- and downstream effectors, as novel pathway linkages can be made.
In addition, the effects of drugs, hormones, or deletion or knockdown of the gene of interest, and the subsequent effects on both the strength of the protein–protein interactions and the location of the interaction can be observed within seconds.
Complex formation in different cellular compartments
BiFC has been used to study nuclear translocation, via complex localisation, as well as interactions involving integral membrane proteins. Thus, BiFC is an important tool in understanding transcription factor localisation in subcellular compartments.
Quantifying protein–protein interaction surfaces
BiFC has been coupled with flow cytometry (BiFC-FC). This allows protein–protein interaction surfaces to be mapped through the introduction of site-directed or random mutations that affect complex formation.
Comparisons to other technologies
Most techniques used to study protein–protein interactions rely on in vitro methods. Unfortunately, studying proteins in an artificial system, outside of their cellular environment, poses a number of difficulties. For example, this may require the removal of proteins from their normal cellular environment.
The processing required to isolate the protein may affect its interactions with other proteins. In addition, isolating the protein from the intracellular signaling and mechanisms that occur in the normal cell may provide a misleading picture of intracellular and physiological occurrences.
Furthermore, proteins studied in vitro may be studied at concentrations vastly different from their normal abundance levels, may not necessarily be transported efficiently into the cells, or may not be selective enough to function in the host genome. Finally, by studying proteins in vitro, one is unable to determine the influence of specific protein–protein interactions in the cell on the functional or physiological consequences.
Other in vivo assays most commonly used to study protein–protein interactions include fluorescence resonance energy transfer (FRET) and yeast two-hybrid (Y2H) assay. Each of these assays has their advantages and disadvantages in comparison to BiFC:
Fluorescence resonance energy transfer (FRET)
Fluorescence resonance energy transfer (FRET), also known as förster resonance energy transfer, resonance energy transfer (RET) or electronic energy transfer (EET), is based on the transfer of energy from an excited (donor) chromophore or fluorophore (if the chromophores are fluorescent) to a nearby acceptor. In this method, fluorophores are chemically linked or genetically fused to two proteins hypothesised to interact.
If the proteins interact, this will bring the fluorophores into close spatial proximity. If the fluorophores are oriented in a manner that exposes the fluorophores to one another, usually ensured when designing and constructing the fluorophore-protein linkage/fusion, then the energy transfer from the excited donor fluorophore will result in a change in the fluorescent intensities or lifetimes of the fluorophores.
Yeast two-hybrid (Y2H)
The yeast two-hybrid (Y2H) is a genetic screening technique that can be used to detect physical (binding) protein–protein or protein–DNA interactions. It is usually applied in the model yeast organism Saccharomyces cerevisiae.
It tests a 'bait' protein of (un)known function that is fused to, for example, the binding domain of the transcription factor GAL4 against potential interacting proteins or a cDNA library that express, for example, the GAL4 activation domain (the 'prey').
External links
Kerppola Lab Online – BiFC Dr. C-D Hu Presentation – Bimolecular Fluorescence Complementation (BiFC): Principles & Applications
Text derived from https://en.wikipedia.org/w/index.php?oldid=1375607792 under CC BY-SA 4.0; modifications have been made.